Rishi Gautam, Executive Chairman of MJardin Group, on their full-scale cannabis business model, the company’s upcoming IPO in Canada, and market growth.
MJardin Group going Public this Autumn
MJardin Group is a specialized professional cannabis management company that provides cultivation solutions, retail advice and operational management on behalf of license-holders. Their Executive Chairman Rishi Gautam discusses their value proposition in the cannabis market and the capital-raising structure in place to become a publicly-listed entity later this calendar year.
MJardin Eyes $200 Million in Cannabis Acquisitions and Its Own Public Debut
MJardin Group Announces Equity Capital Raise to Accelerate Expanding Growth Opportunities
DENVER--(BUSINESS WIRE)--MJardin Group (“MJardin” or the “Company”), a leader in North American cannabis facility management, today announces that it has engaged Canaccord Genuity Corp., to act as sole bookrunner, together with KES 7 Capital Inc. as co-lead agent (collectively, the “Agents”), to sell, on a best efforts private placement basis, pursuant to applicable prospectus and registration exemptions, subscription receipts of MJardin Group (the "Subscription Receipts") to raise equity capital (the “Offering”) to accelerate the Company’s expanding growth opportunities.
MJardin's Exclusive Agreement Partners pick Winnipeg for Canadian Flagship Cannabis Facility
MJardin Announces Launch Of GrowForce
MJardin Group, North America’s largest turnkey operator of legal cannabis facilities, is pleased to announce the creation of a new company called GrowForce Holdings Inc. (“GrowForce”). The mission of GrowForce is to become one of the premium licensed cannabis producers in Canada and other federally legal markets worldwide. GrowForce completed a private placement financing of its shares, which was offered to all of the securities holders of MJardin.
Plugging The Cannabis Knowledge Gap
The legal cannabis industry is a unique prospect for those looking for a potentially lucrative investment opportunity. In 2017, sales in the US state of Colorado reached $1bn in just eight months, a 21 percent increase from the same period in the previous year. According to Statistics Canada, Canadians spent around CAD 5.7bn ($4.5bn) on both medical and non-medical cannabis in 2017, with numbers expected to swell when the latter is legalised in July this year.